Is Insulin Resistance and/or Glucose Intolerance Pathogenetic in the Development of a Reduced Incretin Effect
NCT00784745
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Insulin Resistance
Glucose Intolerance
Interventions
DRUG:
Dexamethasone
Sponsor
University Hospital, Gentofte, Copenhagen